Variantyx, a Framingham, MA-based company which specializes in genomic precision medicine, raised an additional funding of undisclosed amount.

总部位于马萨诸塞州弗雷明汉的Variantyx公司专门从事基因组精密医学研究，该公司还筹集了未披露金额的额外资金。

The round saw participation from Robert Bosch Venture Capital, Pitango HealthTech, New Era Capital Partners, 20/20 HealthCare Partners and Peregrine Ventures.

回合中，Robert Bosch风险投资，Pitango HealthTech，New Era Capital Partners，20/20 HealthCare Partners和Peregrine Ventures参加。

The company intends to use the funds, which brought the total amount to over $120m, to accelerate its commercial expansion.

该公司打算使用这些资金，使总额超过1.2亿美元，以加速其商业扩张。

Led by CEO Haim Neerman, Variantyx is a technology-driven precision medicine company providing solutions for the genetic disorders, reproductive health, and precision oncology markets. Its proprietary whole genome analysis platforms allow clinicians and patients to understand a person’s genetic makeup, diagnostic capabilities and improved personalized treatment recommendations..

Variantyx由首席执行官Haim Neerman领导，是一家技术驱动的精准医学公司，为遗传疾病，生殖健康和精准肿瘤学市场提供解决方案。其专有的全基因组分析平台使临床医生和患者能够了解一个人的基因组成，诊断能力和改进的个性化治疗建议。。

FinSMEs

金融中小企业

19/10/2023

19/10/2023